(Q40880154)

24 September 2017

Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies (English)

1 reference

24 September 2017

0 references

0 references

M Shanahan

4

0 references

author name string

T Wiebe

1

1 reference

24 September 2017

P Fergusson

2

1 reference

24 September 2017

D Horne

3

1 reference

24 September 2017

A Macdonald

5

1 reference

24 September 2017

L Heise

6

1 reference

24 September 2017

L L Roos

7

1 reference

24 September 2017

1 October 1997

1 reference

24 September 2017

Medical Decision Making

1 reference

24 September 2017

17

1 reference

24 September 2017

4

1 reference

24 September 2017

472-482

1 reference

Low-dose intradermal and intramuscular vaccination against hepatitis B

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Five-hundred life-saving interventions and their cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

21 January 2018

Cancer statistics, 1989.

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Outcome of Hepatitis B Virus Infection in Homosexual Men and Its Relation to Prior Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Factors relating to transmission of viral hepatitis in a United States military population stationed in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Incidence of hepatitis among students at a university in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X9701700413

10.1177/0272989X9701700413

21 January 2018

Identifiers

DOI

0 references

1 reference